Cargando…
Clinical and economic outcomes associated with use of anti-arrhythmic drugs versus ablation in atrial fibrillation
AIM: To evaluate the clinical and economic impact of antiarrhythmic drugs (AADs) compared with ablation both as individual treatments and as combination therapy without/with considering the order of treatment among patients with atrial fibrillation (AFib). MATERIALS & METHODS: A budget impact mo...
Autores principales: | Ken-Opurum, Jennifer, Srinivas, Sesha SS, Park, Seojin, Charland, Scott, Revel, Andrew, Preblick, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Becaris Publishing Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508306/ https://www.ncbi.nlm.nih.gov/pubmed/37387403 http://dx.doi.org/10.57264/cer-2023-0065 |
Ejemplares similares
-
A value-based budget impact model for dronedarone compared with other rhythm control strategies
por: Ken-Opurum, Jennifer, et al.
Publicado: (2023) -
Budget Impact Analysis of Intensification with iGlarLixi Compared to Alternative Treatment Strategies Among Patients with Type 2 Diabetes Mellitus
por: Ken-Opurum, Jennifer, et al.
Publicado: (2023) -
Clinical Benefits of Treating Patients with Type 2 Diabetes Mellitus with iGlarLixi: A Patient-Level Simulation Study
por: Chauhan, Ankita, et al.
Publicado: (2023) -
Novel Anti-arrhythmic Medications in the Treatment of Atrial Fibrillation
por: Saklani, Pradyot, et al.
Publicado: (2012) -
Anti-arrhythmic drugs in atrial fibrillation: tailor-made treatments
por: Capucci, Alessandro, et al.
Publicado: (2023)